SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-057094
Filing Date
2024-05-09
Accepted
2024-05-09 16:30:42
Documents
2
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1513
2 EX-24.1 mrus-ex24_1.htm EX-24.1 13752
  Complete submission text file 0000950170-24-057094.txt   16733
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARRAY BIOPHARMA INC., 3200 WALNUT ST BOULDER CO 80301
Business Address
Haddock Jason (Reporting) CIK: 0001680628 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37773 | Film No.: 24931229